Synopsis
Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acamprosate
2. Acamprostate
3. Acetyl Homotaurinate, Calcium
4. Acetylhomotaurinate, Calcium
5. Acetylhomotaurine, Calcium
6. Acetylhomotaurine, Sodium
7. Aotal
8. Calcium Acetyl Homotaurinate
9. Calcium Acetylhomotaurinate
10. Calcium Acetylhomotaurine
11. Campral
12. Campral Ec
13. N Acetylhomotaurine
14. N Acetylhomotaurine, Monolithium Salt
15. N Acetylhomotaurine, Monopotassium Salt
16. N Acetylhomotaurine, Monosodium Salt
17. N-acetylhomotaurine
18. N-acetylhomotaurine, Calcium (2:1) Salt
19. N-acetylhomotaurine, Magnesium (2:1) Salt
20. N-acetylhomotaurine, Monolithium Salt
21. N-acetylhomotaurine, Monopotassium Salt
22. N-acetylhomotaurine, Monosodium Salt
23. N-acetylhomotaurine, Zinc (2:1) Salt
24. Regtect
25. Sodium Acetylhomotaurine
26. Zulex
1. 77337-73-6
2. Campral
3. Campral Ec
4. Alcomed
5. Sobriol
6. Aotal
7. Calcium 3-acetamidopropane-1-sulfonate
8. Calcium Acetylhomotaurinate
9. Acamprosate Calcium [usan]
10. Calcium N-acetylhomotaurinate
11. Calcium 3-(acetylamino)propane-1-sulfonate
12. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
13. Acamprosate (calcium)
14. Nsc-759186
15. Chebi:51042
16. Sn-102
17. 59375n1d0u
18. Calcium Bis(3-acetamidopropane-1-sulfonate)
19. Dsstox_cid_27529
20. Dsstox_rid_82399
21. Dsstox_gsid_47529
22. 77337-73-6 (calcium Salt); 77337-76-9 (free Acid).
23. Calcium Acamprosate
24. Cas-77337-73-6
25. Calcium(2+) 3-(acetylamino)propanesulphonate
26. Ncgc00167462-01
27. Einecs 278-665-3
28. N-acetylhomotaurine Calcium
29. Unii-59375n1d0u
30. Campral (tn)
31. Regtect (tn)
32. Calcium;3-acetamidopropane-1-sulfonate
33. Calcium 3-(acetylamino)propanesulphonate
34. Acamprosate Calcium- Bio-x
35. Schembl137771
36. 3-(acetylamino)-1-propanesulfonic Acid Calcium Salt
37. Acamprosate Calcium [mi]
38. Chembl2068724
39. Dtxsid6047529
40. Acamprosate Calcium (jan/usan)
41. Acamprosate Calcium [jan]
42. Hms3264j11
43. Hms3713l22
44. Pharmakon1600-01505711
45. Acamprosate Calcium [mart.]
46. Tox21_112466
47. Tox21_302606
48. Acamprosate Calcium [usp-rs]
49. Acamprosate Calcium [who-dd]
50. Mfcd00886588
51. Nsc759186
52. Akos015895192
53. Ab07649
54. Ac-5599
55. Calcium 3-acetamido-1-propanesulfonate
56. Ccg-213526
57. Ks-5292
58. Nsc 759186
59. Acamprosate Calcium [orange Book]
60. Ncgc00256899-01
61. Acamprosate Calcium [ep Monograph]
62. Ba164134
63. Acamprosate Calcium [usp Monograph]
64. Db-056209
65. Ft-0621712
66. 3-acetamido-1-propanesulfonate Calcium
67. 3-acetamido-1-propanesulphonate Calcium
68. D02780
69. T71327
70. 3-acetamido-1-propanesulfonic Acid Calcium Salt
71. A839056
72. Calcium 3-(acetylamino)propane-1-sulphonate
73. Q27122289
74. 3-(acetylamino)-1-propanesulfonic Acid Hemicalcium Salt
75. Z1696861853
76. 5-methoxy-2-methyl-1-propyl-1h-indole-3-carboxylicacid
77. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
Molecular Weight | 400.5 g/mol |
---|---|
Molecular Formula | C10H20CaN2O8S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 400.0286988 g/mol |
Monoisotopic Mass | 400.0286988 g/mol |
Topological Polar Surface Area | 189 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 202 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Acamprosate calcium |
Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
Active Ingredient | Acamprosate calcium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 333mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
2 of 2 | |
---|---|
Drug Name | Acamprosate calcium |
Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
Active Ingredient | Acamprosate calcium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 333mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
Alcohol Deterrents
Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21807
Submission : 2008-07-14
Status : Active
Type : II
Certificate Number : R1-CEP 2009-002 - Rev 07
Issue Date : 2021-01-15
Type : Chemical
Substance Number : 1585
Status : Valid
NDC Package Code : 17337-0002
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-13
Pay. Date : 2015-09-18
DMF Number : 22625
Submission : 2009-03-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-07
Pay. Date : 2013-02-15
DMF Number : 21481
Submission : 2008-03-24
Status : Active
Type : II
Date of Issue : 2022-06-03
Valid Till : 2025-05-27
Written Confirmation Number : WC-0003
Address of the Firm :
Registrant Name : Myungin Pharmaceutical Co., Ltd.
Registration Date : 2019-06-21
Registration Number : 20190213-209-J-97(1)
Manufacturer Name : Synthimed Labs Private Limited
Manufacturer Address : Village Bhagwanpur, Barwala Road, Derabassi-140507, District SAS Nagar (Mohali), Punjab, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21348
Submission : 2008-02-20
Status : Active
Type : II
NDC Package Code : 50056-2006
Start Marketing Date : 2008-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-29
Pay. Date : 2014-01-22
DMF Number : 25809
Submission : 2012-03-30
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
NDC Package Code : 14593-873
Start Marketing Date : 2022-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41306
Submission : 2025-02-15
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15819
Submission : 2002-01-23
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23973
Submission : 2010-08-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11995
Submission : 1996-06-10
Status : Inactive
Type : II
Certificate Number : R1-CEP 2007-125 - Rev 00
Issue Date : 2012-11-23
Type : Chemical
Substance Number : 1585
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21348
Submission : 2008-02-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-29
Pay. Date : 2014-01-22
DMF Number : 25809
Submission : 2012-03-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-07
Pay. Date : 2013-02-15
DMF Number : 21481
Submission : 2008-03-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11995
Submission : 1996-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41306
Submission : 2025-02-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-13
Pay. Date : 2015-09-18
DMF Number : 22625
Submission : 2009-03-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21807
Submission : 2008-07-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23973
Submission : 2010-08-25
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15819
Submission : 2002-01-23
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Angelini Fine Chemicals is Angelini Pharma S.p.A. Business Unit fully dedicated to the development and manufacture of small molecules API for the global Pharmaceutical market. Ang...
About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...
About the Company : ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies...
About the Company : Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts ...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Polaris AI Pharma is a dynamic company specializing in innovative pharmaceutical solutions. Leveraging cutting-edge AI technology, it focuses on drug discovery, development, and op...
About the Company : SAI-TECH PHARMACEUTICALS PRIVATE LIMITED is dedicated Active Pharmaceutical Ingredients (API) manufacturing company for producing & providing high quality products as per customer ...
About the Company : Synthimed Labs is a leading API manufacturer recognized for its high-quality and diverse range of Active Pharmaceutical Ingredients (APIs). Their product portfolio includes a wide ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
58
PharmaCompass offers a list of Acamprosate Calcium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acamprosate Calcium manufacturer or Acamprosate Calcium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acamprosate Calcium manufacturer or Acamprosate Calcium supplier.
PharmaCompass also assists you with knowing the Acamprosate Calcium API Price utilized in the formulation of products. Acamprosate Calcium API Price is not always fixed or binding as the Acamprosate Calcium Price is obtained through a variety of data sources. The Acamprosate Calcium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Calcium bisacetyl homotaurine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium bisacetyl homotaurine, including repackagers and relabelers. The FDA regulates Calcium bisacetyl homotaurine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium bisacetyl homotaurine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium bisacetyl homotaurine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium bisacetyl homotaurine supplier is an individual or a company that provides Calcium bisacetyl homotaurine active pharmaceutical ingredient (API) or Calcium bisacetyl homotaurine finished formulations upon request. The Calcium bisacetyl homotaurine suppliers may include Calcium bisacetyl homotaurine API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium bisacetyl homotaurine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calcium bisacetyl homotaurine DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcium bisacetyl homotaurine active pharmaceutical ingredient (API) in detail. Different forms of Calcium bisacetyl homotaurine DMFs exist exist since differing nations have different regulations, such as Calcium bisacetyl homotaurine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcium bisacetyl homotaurine DMF submitted to regulatory agencies in the US is known as a USDMF. Calcium bisacetyl homotaurine USDMF includes data on Calcium bisacetyl homotaurine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcium bisacetyl homotaurine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcium bisacetyl homotaurine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Calcium bisacetyl homotaurine Drug Master File in Korea (Calcium bisacetyl homotaurine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Calcium bisacetyl homotaurine. The MFDS reviews the Calcium bisacetyl homotaurine KDMF as part of the drug registration process and uses the information provided in the Calcium bisacetyl homotaurine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Calcium bisacetyl homotaurine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Calcium bisacetyl homotaurine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Calcium bisacetyl homotaurine suppliers with KDMF on PharmaCompass.
A Calcium bisacetyl homotaurine CEP of the European Pharmacopoeia monograph is often referred to as a Calcium bisacetyl homotaurine Certificate of Suitability (COS). The purpose of a Calcium bisacetyl homotaurine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Calcium bisacetyl homotaurine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Calcium bisacetyl homotaurine to their clients by showing that a Calcium bisacetyl homotaurine CEP has been issued for it. The manufacturer submits a Calcium bisacetyl homotaurine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Calcium bisacetyl homotaurine CEP holder for the record. Additionally, the data presented in the Calcium bisacetyl homotaurine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Calcium bisacetyl homotaurine DMF.
A Calcium bisacetyl homotaurine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Calcium bisacetyl homotaurine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Calcium bisacetyl homotaurine suppliers with CEP (COS) on PharmaCompass.
A Calcium bisacetyl homotaurine written confirmation (Calcium bisacetyl homotaurine WC) is an official document issued by a regulatory agency to a Calcium bisacetyl homotaurine manufacturer, verifying that the manufacturing facility of a Calcium bisacetyl homotaurine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium bisacetyl homotaurine APIs or Calcium bisacetyl homotaurine finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium bisacetyl homotaurine WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium bisacetyl homotaurine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calcium bisacetyl homotaurine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calcium bisacetyl homotaurine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calcium bisacetyl homotaurine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calcium bisacetyl homotaurine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calcium bisacetyl homotaurine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calcium bisacetyl homotaurine suppliers with NDC on PharmaCompass.
Calcium bisacetyl homotaurine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium bisacetyl homotaurine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium bisacetyl homotaurine GMP manufacturer or Calcium bisacetyl homotaurine GMP API supplier for your needs.
A Calcium bisacetyl homotaurine CoA (Certificate of Analysis) is a formal document that attests to Calcium bisacetyl homotaurine's compliance with Calcium bisacetyl homotaurine specifications and serves as a tool for batch-level quality control.
Calcium bisacetyl homotaurine CoA mostly includes findings from lab analyses of a specific batch. For each Calcium bisacetyl homotaurine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium bisacetyl homotaurine may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium bisacetyl homotaurine EP), Calcium bisacetyl homotaurine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium bisacetyl homotaurine USP).